Iradimed (IRMD) Return on Capital Employed Growth (1y) (2015 - 2026)
Iradimed (IRMD) Return on Capital Employed Growth (1y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.74 Bn | 176.45 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.89 Bn | 126.01 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.48 Bn | 99.26 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.51 Bn | 67.05 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.32 Bn | 44.65 Bn | 1.29 Bn | -110.00 |
| 6 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 658.00 |
| 7 | GE HealthCare Technologies | 28.23 Bn | 25.95 Bn | 1.98 Bn | -3,185.00 |
| 8 | Smith & Nephew | 26.90 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.47 Bn | 21.35 Bn | 2.07 Bn | 125.00 |
| 10 | Iradimed | 1.22 Bn | 1.16 Bn | 16.81 Mn | 337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 337.00 |
| Dec 31, 2025 | 72.00 |
| Sep 30, 2025 | 4.00 |
| Jun 30, 2025 | -131.00 |
| Mar 31, 2025 | -46.00 |
| Dec 31, 2024 | -225.00 |
| Sep 30, 2024 | 38.00 |
| Jun 30, 2024 | 183.00 |
| Mar 31, 2024 | 276.00 |
| Dec 31, 2023 | 615.00 |
| Sep 30, 2023 | 489.00 |
| Jun 30, 2023 | 468.00 |
| Mar 31, 2023 | 687.00 |
| Dec 31, 2022 | 783.00 |
| Sep 30, 2022 | 969.00 |
| Jun 30, 2022 | 1,230.00 |
| Mar 31, 2022 | 1,515.00 |
| Dec 31, 2021 | 1,445.00 |
| Sep 30, 2021 | 913.00 |
| Jun 30, 2021 | 343.00 |